January 5, 2017 / 12:56 PM / 9 months ago

BRIEF-Orexigen therapeutics anticipates filing of new drug submission for Contrave

Jan 5 (Reuters) - Orexigen Therapeutics Inc :

* Anticipates filing of new drug submission for contrave with Health Canada by partner, Valeant Canada in Q1 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below